Basic info
Industry
biotechnology research
Sectors
Biotechnology
neurodegeneration
Drug discovery and development
biomarker discovery
epigenetics
Health Care
Therapeutics
Genetics
Medical
clinical trials
cancer
Biopharma
Date founded
2000
Funding rounds raised
Total raised
$21M
from 4 investors over 4 rounds
O
Oryzon Genomics SA raised $425K on December 16, 2022
Investors: European Union
O
Oryzon Genomics SA raised $21M on July 5, 2022
Investors: Nice & Green SA, Proprietary Equity Investment & Alternative Financing
O
Oryzon Genomics SA raised $2M on June 7, 2022
Investors: European Commission
O
Oryzon Genomics SA raised $1M on September 21, 2021
Investors: Kabuki Syndrome Foundation